Doug Treco, Ph.D.
InvestorAdvisor at Lightstone Ventures
Find your path to Doug
41 people in our graph share verified history with Doug — schools, employers, funds. One of them is your warm intro.
Adam BruceunlockedDoug: together at Lightstone Ventures
×11Doug: together at Lightstone Ventures
About
Advisor to Lightstone Ventures and co-founder of Ra Pharmaceuticals, serving as CEO until its 2020 acquisition by UCB. Doug also co-founded Transkaryotic Therapies (acquired by Shire in 2005) and served as Entrepreneur-in-Residence at Morgenthaler Ventures.
Colleagues at Lightstone Ventures
Caroline Gaynor
Partner at Lightstone Ventures
Christina Isacson
Partner at Lightstone Ventures
Christina Isacson, Ph.D.
Partner at Lightstone Ventures
Doug Treco
Advisor at Lightstone Ventures
Frank D. Lee
Advisor at Lightstone Ventures
H. Martin Seidel
Advisor at Lightstone Ventures
H. Martin Seidel, Ph.D.
Advisor at Lightstone Ventures
Hank Plain
Founding Partner & Advisor at Lightstone Ventures
Frequently asked questions
- Who is Doug Treco, Ph.D.?
- Advisor to Lightstone Ventures and co-founder of Ra Pharmaceuticals, serving as CEO until its 2020 acquisition by UCB. Doug also co-founded Transkaryotic Therapies (acquired by Shire in 2005) and served as Entrepreneur-in-Residence at Morgenthaler Ventures.
- Where does Doug Treco, Ph.D. work?
- Doug Treco, Ph.D. is Advisor at Lightstone Ventures.